| Primary |
| Product Used For Unknown Indication |
17.9% |
| Alcoholic Psychosis |
8.4% |
| Insomnia |
8.4% |
| Irritability |
8.4% |
| Bipolar I Disorder |
6.1% |
| Schizophrenia |
5.7% |
| Depression |
5.1% |
| Mental Disorder |
5.1% |
| Schizophrenia, Paranoid Type |
5.1% |
| Drug Use For Unknown Indication |
4.7% |
| Psychotic Disorder |
4.7% |
| Mania |
4.4% |
| Constipation |
3.0% |
| Anxiety |
2.4% |
| Catatonia |
2.4% |
| Senile Dementia |
2.4% |
| Delirium |
1.7% |
| Atrial Fibrillation |
1.4% |
| Bipolar Disorder |
1.4% |
| Diabetes Mellitus |
1.4% |
|
| Neuroleptic Malignant Syndrome |
48.1% |
| Hepatitis Toxic |
7.7% |
| Restlessness |
7.7% |
| Large Intestine Perforation |
3.8% |
| Tardive Dyskinesia |
3.8% |
| Anticholinergic Syndrome |
1.9% |
| Catatonia |
1.9% |
| Delirium |
1.9% |
| Drug Interaction |
1.9% |
| Dysphagia |
1.9% |
| Hallucination |
1.9% |
| Hallucination, Visual |
1.9% |
| Hepatic Encephalopathy |
1.9% |
| Hip Fracture |
1.9% |
| Hyponatraemia |
1.9% |
| Hypothermia |
1.9% |
| Myasthenia Gravis |
1.9% |
| Pallanaesthesia |
1.9% |
| Pemphigus |
1.9% |
| Renal Failure |
1.9% |
|
| Secondary |
| Drug Use For Unknown Indication |
16.2% |
| Schizophrenia |
13.1% |
| Product Used For Unknown Indication |
12.3% |
| Insomnia |
9.4% |
| Irritability |
6.6% |
| Alcoholic Psychosis |
6.3% |
| Depression |
6.3% |
| Mental Disorder |
4.4% |
| Parkinson's Disease |
3.4% |
| Agitation |
3.1% |
| Bipolar I Disorder |
2.6% |
| Constipation |
2.6% |
| Psychotic Disorder |
2.1% |
| Drug Exposure During Pregnancy |
1.9% |
| Acute Psychosis |
1.7% |
| Anxiety |
1.6% |
| Diabetes Mellitus |
1.6% |
| Schizophrenia, Paranoid Type |
1.6% |
| Mania |
1.5% |
| Extrapyramidal Disorder |
1.5% |
|
| Neuroleptic Malignant Syndrome |
15.7% |
| Suicide Attempt |
13.9% |
| Tremor |
7.8% |
| Delirium |
6.1% |
| Tardive Dyskinesia |
6.1% |
| Cardiac Failure |
5.2% |
| Pulmonary Embolism |
4.3% |
| Respiratory Failure |
4.3% |
| Vomiting |
4.3% |
| Emotional Disorder |
3.5% |
| Restlessness |
3.5% |
| Schizophrenia |
3.5% |
| Tachycardia |
3.5% |
| Cardiac Failure Acute |
2.6% |
| Drug Ineffective |
2.6% |
| Extrapyramidal Disorder |
2.6% |
| Opiates Positive |
2.6% |
| Overdose |
2.6% |
| Pallanaesthesia |
2.6% |
| Syncope |
2.6% |
|
| Concomitant |
| Schizophrenia |
33.1% |
| Drug Use For Unknown Indication |
11.1% |
| Product Used For Unknown Indication |
6.7% |
| Depression |
6.5% |
| Insomnia |
5.8% |
| Schizophrenia, Paranoid Type |
4.6% |
| Hiv Infection |
3.8% |
| Parkinsonism |
3.2% |
| Bipolar Disorder |
2.9% |
| Extrapyramidal Disorder |
2.9% |
| Prophylaxis |
2.8% |
| Constipation |
2.6% |
| Psychotic Disorder |
2.6% |
| Anxiety |
2.2% |
| Diabetes Mellitus |
1.9% |
| Delusion |
1.9% |
| Parkinson's Disease |
1.6% |
| Bipolar I Disorder |
1.4% |
| Epilepsy |
1.4% |
| Oropharyngeal Pain |
1.3% |
|
| Rhabdomyolysis |
9.9% |
| Schizophrenia |
9.9% |
| Weight Decreased |
9.9% |
| Weight Increased |
9.9% |
| Somnolence |
5.8% |
| Suicide Attempt |
5.8% |
| Tremor |
5.8% |
| Completed Suicide |
4.5% |
| Psychotic Disorder |
4.5% |
| Restlessness |
4.1% |
| Pancytopenia |
3.7% |
| Salivary Hypersecretion |
3.7% |
| Loss Of Consciousness |
3.3% |
| Dyskinesia |
2.9% |
| Hallucination |
2.9% |
| Platelet Count Decreased |
2.9% |
| Ventricular Tachycardia |
2.9% |
| Drug Interaction |
2.5% |
| Dry Eye |
2.5% |
| Neuroleptic Malignant Syndrome |
2.5% |
|
| Interacting |
| Schizophrenia |
42.1% |
| Drug Use For Unknown Indication |
23.7% |
| Product Used For Unknown Indication |
21.1% |
| Bipolar Disorder |
7.9% |
| Depression |
2.6% |
| Restlessness |
2.6% |
|
| Neuroleptic Malignant Syndrome |
42.9% |
| Sudden Death |
28.6% |
| Drug Interaction |
14.3% |
| Speech Disorder |
14.3% |
|
